Lisanti Capital Growth LLC purchased a new position in PROCEPT BioRobotics Co. (NASDAQ:PRCT Free Report) in the second quarter, according to its most recent Form 13F filing with the...
PROCEPT BioRobotics Co. (NASDAQ:PRCT Get Free Report) Director Morgan Colby Wood sold 25,000 shares of PROCEPT BioRobotics stock in a transaction that occurred on Monday, November 13th. The...
SAN JOSE, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the Company ), a surgical robotics company focused on advancing patient care by developing transformative...
Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT Get Free Report) have earned an average recommendation of Buy from the six research firms that are currently covering the firm...
PROCEPT BioRobotics Co. (NASDAQ:PRCT Get Free Report) has been assigned a consensus recommendation of Buy from the six research firms that are covering the stock, MarketBeat...
In trading on Friday, shares of PROCEPT BioRobotics Corp (PRCT) crossed above their 200 day moving average of 33.33, changing hands as high as 34.99 per share. PROCEPT BioRobotics Corp...
SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the Company ), a surgical robotics company focused on advancing patient care by developing...
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in PROCEPT BioRobotics Corp (PRCT), where a total of 5,646 contracts have traded so far...
SVB Leerink assumed coverage on shares of PROCEPT BioRobotics (NASDAQ:PRCT Free Report) in a research report sent to investors on Monday morning, Benzinga reports. The firm issued an...